Company intelligence / Profile preview
Ignis Therapeutics
Shanghai, Shanghai, China
- Ownership
- Private
- Employees
- ~100
- Development stage
- Phase 3
01
Overview
Ignis Therapeutics is a Shanghai-based biotech company founded in 2020 focused on developing innovative therapies for central nervous system diseases. The company has over 20 pipeline programs targeting major neurological disorders. Its lead program is cenobamate for epilepsy, which has reached the New Drug Application stage in China. Other advanced assets include solriamfetol for excessive daytime sleepiness and several additional candidates licensed from SK biopharmaceuticals. The company combines internal R&D with strategic licensing to address unmet needs across the CNS spectrum.
- Therapeutic areas
- PsychiatryNeurology
- Modalities
- Small molecules
- Industry
- Biotech
02
Drug pipeline
5 assets4 more assets in the full pipeline.
Request access →03
Partnerships
SK biopharmaceuticals – exclusive commercialization rights to multiple CNS drugs including cenobamate, solriamfetol, carisbamate.Academic collaborations with domestic/international institutions mentioned but not named specifically.
Beyond the preview
Go deeper on Ignis Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Ignis Therapeutics.